Phenotypic discordance in semilobar holoprosencephaly: a case report of total arhinia and median clefting linked to gestational diabetes
Abstract
Introduction: Holoprosencephaly (HPE) is a complex spectrum of cephalic malformations resulting from incomplete prosencephalic division. Semilobar HPE is an intermediate variant, often associated with significant craniofacial dysmorphism and neurological morbidity.
Case presentation: We present a preterm female infant born to a mother with unmanaged gestational diabetes. At birth, she exhibited microcephaly, total arhinia, and a median cleft lip and palate. MRI confirmed semilobar HPE. Clinical progression included hypotonia, seizures, and recurrent hyperpyrexia associated with hypothalamic dysfunction. Despite the absence of a nasal airway, the infant transitioned to reflexive mouth breathing and required long-term orogastric tube feeding. Notably, she has maintained systemic stability throughout an 8-month follow-up, facilitated by a proactive, multidisciplinary home-based care model.
Discussion: This case illustrates a phenotypic discordance in which severe arhinia occurs alongside intermediate cerebral cleavage, suggesting a potential vulnerability in which nasal placode development may be highly sensitive to maternal hyperglycemia, which is hypothesized to perturb cholesterol-dependent Sonic Hedgehog signaling. Our clinical experience demonstrates that by prioritizing rigorous caloric titration and proactive monitoring of autonomic and infectious triggers, it is possible to successfully navigate the patient's precarious equilibrium and prevent the secondary morbidity…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.